News
Stories and articles featuring PCI, our partners, and Penn-affiliated spinout companies
Stories and articles featuring PCI, our partners, and Penn-affiliated spinout companies
Capstan Therapeutics, a biotechnology company spun out of Penn, has initiated its Phase 1 trial of an in vivo CAR-T therapy.
REGENXBIO was co-founded by James M. Wilson, MD, PhD, the Rose H. Weiss Orphan Disease Center Director's Professor in Penn Medicine.
Vivodyne was co-founded by Dan Huh, PhD, Professor of Bioengineering in Penn Engineering and CEO Andrei Georgescu.,
Penn has over 5,000 research faculty spanning 200+ centers.
The 2025 Global Startup Ecosystem Report has been released.
Researchers developed a smart dental implant that prevents gum inflammation and plaque formation.
In a history-making breakthrough, a baby diagnosed with a rare genetic disorder was successfully treated with a customized CRISPR gene editing therapy.
Melissa Kelly, PhD, Deputy Managing Director of PCI, served as a panelist and shared her insights on the impact of AI.
The 15th annual Philly Tech Week took place from May 5 - 10, 2025, with the goal of celebrating innovation and empowering startups in the region’s thriving tech ecosystem.
The PCI Fellows program is an internship opportunity in technology commercialization that is open to graduate students, postdoctoral fellows and junior research staff at Penn.